kore group hldgs i com - KORE
KORE
Close Chg Chg %
1.22 -0.04 -3.28%
Closed Market
1.18
-0.04 (3.28%)
Volume: 113.08K
Last Updated:
Dec 13, 2024, 3:58 PM EDT
Company Overview: kore group hldgs i com - KORE
KORE Key Data
| Open $1.37 | Day Range 1.14 - 1.46 |
| 52 Week Range 1.14 - 6.45 | Market Cap $20.92M |
| Shares Outstanding 17.01M | Public Float 5.00M |
| Beta 2.34 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$8.47 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 37.15K |
KORE Performance
| 1 Week | -19.31% | ||
| 1 Month | -41.50% | ||
| 3 Months | -50.21% | ||
| 1 Year | -55.00% | ||
| 5 Years | N/A |
KORE Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
3
Full Ratings ➔
About kore group hldgs i com - KORE
KORE Group Holdings, Inc. engages in the provision of Internet of things (IoT) solutions and worldwide IoT connectivity-as-a-services. It offers connectivity-enablement as-a-service, IoT device management services, IoT security and location-based services. The company was founded in 2002 and is headquartered in Atlanta, GA.
KORE At a Glance
KORE Group Holdings, Inc.
3 Ravinia Drive
Atlanta, Georgia 30346
| Phone | 1-877-710-5673 | Revenue | 276.61M | |
| Industry | Information Technology Services | Net Income | -167,042,000.00 | |
| Sector | Technology Services | 2023 Sales Growth | 3.041% | |
| Fiscal Year-end | 12 / 2024 | Employees | 600 | |
| View SEC Filings |
KORE Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.297 |
| Price to Book Ratio | 2.052 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 13.147 |
| Enterprise Value to Sales | 1.83 |
| Total Debt to Enterprise Value | 0.891 |
KORE Efficiency
| Revenue/Employee | 461,016.667 |
| Income Per Employee | -278,403.333 |
| Receivables Turnover | 5.073 |
| Total Asset Turnover | 0.427 |
KORE Liquidity
| Current Ratio | 1.369 |
| Quick Ratio | 1.259 |
| Cash Ratio | 0.364 |
KORE Profitability
| Gross Margin | 32.423 |
| Operating Margin | -8.024 |
| Pretax Margin | -61.892 |
| Net Margin | -60.389 |
| Return on Assets | -25.787 |
| Return on Equity | -153.50 |
| Return on Total Capital | -34.222 |
| Return on Invested Capital | -30.702 |
KORE Capital Structure
| Total Debt to Total Equity | 1,220.169 |
| Total Debt to Total Capital | 92.425 |
| Total Debt to Total Assets | 74.345 |
| Long-Term Debt to Equity | 1,209.45 |
| Long-Term Debt to Total Capital | 91.613 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Kore Group Hldgs I Com - KORE
Collapse All in section
| All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| - | 248.22M | 268.45M | 276.61M | |
Sales Growth
| - | - | +8.15% | +3.04% | - |
Cost of Goods Sold (COGS) incl D&A
| - | 172.64M | 183.65M | 186.93M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| - | 50.41M | 56.72M | 60.69M | |
Depreciation
| - | - | 5.92M | 7.93M | - |
Amortization of Intangibles
| - | - | 50.80M | 52.76M | - |
COGS Growth
| - | - | +6.38% | +1.78% | - |
Gross Income
| - | 75.58M | 84.79M | 89.68M | |
Gross Income Growth
| - | - | +12.19% | +5.77% | - |
Gross Profit Margin
| - | +30.45% | +31.59% | +32.42% |
| 2020 | 2021 | 2022 | 2023 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 672.97K | 91.63M | 96.01M | 111.88M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 672.97K | 91.63M | 96.01M | 111.88M | |
SGA Growth
| - | +13,516.25% | +4.77% | +16.53% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 3.77M | (5.17M) | 74.03M | 105.58M | |
EBIT after Unusual Expense
| (4.45M) | (10.89M) | (85.25M) | (127.78M) | |
Non Operating Income/Expense
| - | - | (446.27K) | (187.00K) | - |
Non-Operating Interest Income
| - | - | - | 552.00K | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| - | 23.26M | 31.37M | 43.23M | |
Interest Expense Growth
| - | - | +34.87% | +37.81% | - |
Gross Interest Expense
| - | 23.26M | 31.37M | 43.23M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (4.89M) | (34.15M) | (116.62M) | (171.20M) | |
Pretax Income Growth
| - | -597.73% | -241.51% | -46.81% | |
Pretax Margin
| - | -13.76% | -43.44% | -61.89% | |
Income Tax
| - | (9.69M) | (10.42M) | (4.16M) | |
Income Tax - Current - Domestic
| - | 177.00K | 5.21M | 6.53M | |
Income Tax - Current - Foreign
| - | - | 558.00K | 723.00K | - |
Income Tax - Deferred - Domestic
| - | (9.87M) | (13.79M) | (9.53M) | |
Income Tax - Deferred - Foreign
| - | - | (2.40M) | (1.89M) | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (4.89M) | (24.45M) | (106.20M) | (167.04M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (4.89M) | (24.45M) | (106.20M) | (167.04M) | |
Net Income Growth
| - | -399.65% | -334.30% | -57.29% | |
Net Margin Growth
| - | -9.85% | -39.56% | -60.39% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (4.89M) | (24.45M) | (106.20M) | (167.04M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (4.89M) | (24.45M) | (106.20M) | (167.04M) | |
EPS (Basic)
| -0.7368 | -2.9157 | -7.0135 | -9.9658 | |
EPS (Basic) Growth
| - | -295.72% | -140.54% | -42.09% | |
Basic Shares Outstanding
| 6.64M | 8.39M | 15.14M | 16.76M | |
EPS (Diluted)
| -0.7368 | -2.9157 | -7.0135 | -9.9658 | |
EPS (Diluted) Growth
| - | -295.72% | -140.54% | -42.09% | |
Diluted Shares Outstanding
| 6.64M | 8.39M | 15.14M | 16.76M | |
EBITDA
| (672.97K) | 34.36M | 45.51M | 38.50M | |
EBITDA Growth
| - | +5,205.73% | +32.44% | -15.40% | |
EBITDA Margin
| - | +13.84% | +16.95% | +13.92% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 8.125 | |
| Number of Ratings | 3 | Current Quarters Estimate | -0.49 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | -5.63 | |
| Last Quarter’s Earnings | -1.00 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -9.989 | Next Fiscal Year Estimate | -1.435 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 2 | 1 | 2 | 2 |
| Mean Estimate | -0.49 | -0.53 | -5.63 | -1.44 |
| High Estimates | -0.47 | -0.53 | -5.47 | -1.28 |
| Low Estimate | -0.51 | -0.53 | -5.79 | -1.59 |
| Coefficient of Variance | -5.77 | N/A | -4.02 | -15.28 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 1 | 1 | 2 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 2 | 2 | 3 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Kore Group Hldgs I Com - KORE
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Kore Group Hldgs I Com - KORE
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Aug 20, 2024 | Jared Deith EVP, Connected Health | 24,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 8, 2024 | Bruce William Gordon Exec. Vice Pres. & COO | 100,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 9, 2024 | Louise P. Winstone EVP, Chief HR Officer | 64,093 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 9, 2024 | Paul Holtz Exec. Vice Pres., CFO & Treas. | 16,109 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 9, 2024 | Paul Holtz Exec. Vice Pres., CFO & Treas. | 67,758 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $0.71 per share | 48,108.18 |
| Apr 9, 2024 | Paul Holtz Exec. Vice Pres., CFO & Treas. | 77,533 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 9, 2024 | Bryan Lubel Exec. VP., Connected Health | 16,109 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 9, 2024 | Bryan Lubel Exec. VP., Connected Health | 118,364 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 9, 2024 | Tushar K. Sachdev EVP & Chief Technology Officer | 160,096 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 9, 2024 | Louise P. Winstone EVP, Chief HR Officer | 71,427 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $0.71 per share | 50,713.17 |
| Apr 9, 2024 | Louise P. Winstone EVP, Chief HR Officer | 75,394 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 9, 2024 | Jack William Kennedy EVP, Chief Legal Officer & Sec | 11,276 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 9, 2024 | Jack William Kennedy EVP, Chief Legal Officer & Sec | 85,472 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 9, 2024 | Tushar K. Sachdev EVP & Chief Technology Officer | 16,109 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 14, 2024 | Bryan Lubel Exec. VP., Connected Health | 74,129 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 14, 2024 | Romil Bahl Pres., Chief Executive Officer; Director | 593,040 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 14, 2024 | Romil Bahl Pres., Chief Executive Officer; Director | 1,164,134 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |